VANECK ETF TRUST - PHARMACEUTCL ETF (PPH)

Historical Holders from Q1 2016 to Q3 2025

Symbol
PPH
Type / Class
Equity / PHARMACEUTCL ETF
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
7,884,687
Holdings value
$712,426,870
% of all portfolios
0%
Number of holders
123
Number of buys
56
Number of sells
-61
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 7,884,687 $712,426,870 -$3,735,743 $90.36 123
2025 Q2 7,771,917 $683,617,119 +$174,839,485 $87.96 126
2025 Q1 5,812,878 $529,776,765 -$16,593,374 $91.13 133
2024 Q4 5,968,612 $514,991,591 +$11,463,960 $86.28 140
2024 Q3 5,722,368 $543,596,181 +$86,910,938 $95.03 140
2024 Q2 4,815,475 $440,503,835 +$20,148,731 $91.48 139
2024 Q1 4,560,967 $413,738,555 -$6,570,269 $90.7 135
2023 Q4 4,735,950 $385,640,268 -$16,334,775 $81.37 108
2023 Q3 5,055,242 $403,877,688 +$20,782,635 $79.86 101
2023 Q2 4,968,295 $391,351,030 +$6,082,356 $78.77 101
2023 Q1 4,592,895 $356,545,144 -$174,679,110 $77.63 104
2022 Q4 6,556,396 $509,704,617 +$29,919,137 $77.74 111
2022 Q3 6,321,313 $426,561,742 +$118,107,484 $67.24 85
2022 Q2 4,502,840 $345,999,696 +$274,153,350 $76.84 90
2022 Q1 882,288 $70,469,084 +$7,531,365 $79.76 74
2021 Q4 769,399 $59,210,150 -$6,214,856 $76.95 61
2021 Q3 775,415 $56,458,804 +$3,053,753 $72.81 49
2021 Q2 861,370 $62,932,502 -$121,700,494 $73.07 52
2021 Q1 2,722,467 $187,899,411 +$79,801,407 $69.02 51
2020 Q4 1,391,267 $92,698,931 -$36,792,997 $66.48 48
2020 Q3 1,950,775 $121,269,474 +$26,966,047 $62.17 46
2020 Q2 1,517,324 $94,463,969 +$34,775,889 $62.25 47
2020 Q1 1,060,989 $57,742,871 -$79,299,356 $54.39 44
2019 Q4 3,207,826 $205,589,007 +$10,968,047 $64.18 48
2019 Q3 2,269,401 $129,276,499 +$52,001,851 $56.95 43
2019 Q2 952,757 $55,873,605 -$3,054,320 $58.67 40
2019 Q1 1,002,623 $60,875,954 -$33,883,025 $60.71 44
2018 Q4 1,560,984 $85,560,052 -$19,773,375 $54.79 44
2018 Q3 1,899,381 $122,176,472 -$19,204,656 $64.34 42
2018 Q2 2,214,462 $130,530,022 +$13,765,279 $59 48
2018 Q1 1,982,906 $112,643,688 +$23,538,488 $56.82 51
2017 Q4 1,567,774 $93,015,784 -$67,109,351 $59.31 49
2017 Q3 2,357,266 $136,154,624 +$67,642,279 $57.76 46
2017 Q2 1,201,989 $70,984,650 -$41,248,475 $59.06 48
2017 Q1 1,901,736 $104,884,746 +$2,251,433 $55.14 49
2016 Q4 1,861,501 $97,792,252 -$64,452,979 $52.51 48
2016 Q3 3,071,963 $176,501,646 +$41,474,999 $57.45 56
2016 Q2 2,322,425 $136,167,310 +$135,429,458 $58.62 52
2016 Q1 10,828 $623,000 +$623,000 $57.52 2